Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Article uri icon

Overview

publication date

  • June 1, 2007

Research

keywords

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Still's Disease, Adult-Onset

Identity

PubMed Central ID

  • PMC1954650

Scopus Document Identifier

  • 34249799278

PubMed ID

  • 17513574

Additional Document Info

volume

  • 66

issue

  • 6